In patients with subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y in those with previous stroke or TIA.
Sign Up to like & getrecommendations! Published in 2025 at "Annals of internal medicine"
DOI: 10.7326/annals-25-01330-jc
Abstract: CLINICAL IMPACT RATINGS GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Neurology: [Formula: see text] Hematology: [Formula: see text]. read more here.
Keywords: subclinical apixaban; see text; apixaban aspirin; patients subclinical ... See more keywords